Chance Scott is a director in Navigant’s Life Sciences practice, joining the Firm through Navigants acquisition of Quorum Consulting, a full-service Life Science reimbursement consulting firm.
Chance operates as a key member of Navigant's Market Access Center of Excellence. Chance has a deep understanding of reimbursement mechanics, including medical policy development, novel coding pathways, and payment policy across settings of care. He leads many of the Firm’s engagements for advanced diagnostics, as well as practice areas focusing on payer engagement and pricing strategies.
Prior to joining Navigant (previously Quorum), Chance worked in a variety of capacities supporting commercial organizations. He spearheaded a number of launch readiness engagements while at Campbell Alliance Consulting Group. Additionally, he held several roles in the commercial organization at Genentech, including sales training and oncology field sales.